What is Samsara BioCapital?

Samsara BioCapital is a Venture Capital based in Palo Alto.

How many investments has Samsara BioCapital made?

Samsara BioCapital has made 44 disclosed investments.

How much does Samsara BioCapital manage?

Samsara BioCapital manages $410.0M in assets.

What does Samsara BioCapital invest in?

Samsara BioCapital invests in Biotech, Life Sciences Seed, Early Stage, Growth companies.

What companies has Samsara BioCapital invested in?

Samsara BioCapital's portfolio includes DELFI Diagnostics, VTV Therapeutics, Genalyte, Abcuro, Ottimo, Eyebiotech Limited.

Samsara BioCapital

Venture Capital

Samsara BioCapital is a Palo Alto, California life sciences venture capital firm investing in biotech and therapeutics companies. Founded by scientists, physicians, drug developers, and business leaders with over 500 years combined experience, the firm backs entrepreneurs developing transformative therapeutics for patients.

Palo Alto, United States · 44+ investments · 74 portfolio companies

Website

Seed

Early Stage

Growth

Biotech

Life Sciences

Headquarters: Palo Alto, United States
Founded: 2016
Website: samsaracap.com
AUM: $410.0M

Portfolio Companies: 74
Total Investments: 44
Last Investment: Feb 2026
Geographic Focus: Europe, United States

Investment Thesis

We invest by helping entrepreneurs develop their ideas into successful...

Samsara BioCapital is a Venture Capital firm based in Palo Alto, United States. It has made 44 investments in Biotech and Life Sciences, including DELFI Diagnostics, VTV Therapeutics and Genalyte.